Table 6. Mean QLQ-PR25 Scores at Baseline and after the Intervention.
| Subscales | Baseline (pre intervention) | Follow Up (post intervention) | ||||
|---|---|---|---|---|---|---|
| Intervention Group | Control Group | p† | InterventionGroup | Control Group | p† | |
| Unirary Symptoms | 72 (20.1) | 55 (17.3) | <0.0001 | 61 (22.1) | 56 (17.0) | 0.0704 |
| Incontinence aid* | 80 (15.0) | 72 (23.0) | 0.0037 | 78 (19.1) | 75 (20.0) | 0.271 |
| Bowel symptoms | 36 (24.0) | 35 (21.2) | 0.751 | 35 (21.2) | 46 (20.7) | 0.0003 |
| Treatment-related symptoms | 78 (19.1) | 81 (15.0) | 0.211 | 67 (21.9) | 92 (11.4) | <0.0001 |
| Sexual interest | 94 (9.2) | 90 (13.4) | 0.0137 | 82 (15.0) | 90 (13.4) | 0.0009 |
| Sexual functioning** | 90 (13.4) | 95 (8.2) | 0.00159 | 78 (19.2) | 91 (9.8) | <0.0001 |
* Patients who wear incontinence aids only
** Patients who were sexually active only
† independent samples t-test